CAR T-cell therapy (Zhujiang Hospital)

CAR-T细胞疗法（珠江医院）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCAR T-cell therapy (Zhujiang Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesSouthern Medical University Zhujing Hospital

China Registration ClassN/A

Develop Information

Active CompaniesSouthern Medical University Zhujing Hospital

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A